Angioplasty Balloons Market to Reach $3.36 Billion by 2029, Growing at a CAGR of 4.3%
Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Global Market Value Of The Angioplasty Balloons Industry In 2025?
The market for angioplasty balloons has witnessed consistent expansion over the past few years, projected to increase from a value of $2.73 billion in 2024 to $2.85 billion in the following year, achieving a compound annual growth rate (CAGR) of 4.5%. This expansion throughout the historical timeframe is largely credited to several key factors, including a rise in ongoing clinical investigations, the easing of regulatory obstacles, the proliferation of physician training initiatives, broader insurance reimbursement frameworks, and heightened patient understanding and educational outreach.
Anticipation surrounds the angioplasty balloons sector, projecting consistent expansion through the coming years, with its valuation set to reach $3.36 billion by 2029, reflecting a compound annual growth rate (CAGR) of 4.3%. This projected upward trajectory during the forecast timeframe is fueled by several key factors: an increasing elderly demographic, the escalating incidence of heart and circulatory ailments, the enhancement of medical facilities in developing economies, greater acceptance of procedures requiring minimal intrusion, and the mounting need for cardiac interventions. Over the forecast period, notable developments are expected to shape the market, such as the customization of therapies, the incorporation of sophisticated imaging tools, a movement towards procedures conducted outside traditional hospital settings, the broadening use of remote monitoring for recovery management, and a concentration on healthcare options that offer superior value.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15509&type=smp
What Are The Emerging Market Drivers Creating New Opportunities In The Angioplasty Balloons Industry?
Anticipated growth in the angioplasty balloons sector is primarily fueled by the escalating prevalence of cardiovascular ailments, which encompass various heart and blood vessel conditions frequently resulting in severe outcomes like strokes or myocardial infarctions.This upward trend in cardiovascular issues is largely attributable to increasingly sedentary routines, poor nutritional choices, escalating obesity levels, and demographic shifts toward older populations.Angioplasty balloons serve a crucial role in managing these conditions by expanding constricted or obstructed vasculature, thereby normalizing circulatory function and mitigating the potential for adverse events. Illustratively, data released in September 2024 by the Minnesota Department of Health, a state-level public health authority in the US, indicated that close to 30% of adults in Minnesota were diagnosed with hypertension in 2023, amounted to nearly 1.4 million individuals, further evidenced by hypertensive disorders being a primary or secondary factor in 14,225 fatalities among state residents in 2022, accounting for nearly 28% of total mortality; consequently, the rising occurrence of heart and circulatory diseases acts as a significant stimulus for the expansion of the market for angioplasty balloons.
How Is The Angioplasty Balloons Market Classified Into Different Segments?
The angioplasty balloonsmarket covered in this report is segmented –
1) By Product Type: Normal Balloons, Scoring Balloons, Drug-Eluting Balloons, Cutting Balloons
2) By Material: Non-Compliant, Semi-Compliant
3) By Application: Coronary Angioplasty, Peripheral Angioplasty
4) By End User: Hospitals, Specialty Clinics, Catheterization Laboratories, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Normal Balloons: Non-Compliant Balloons, Compliant Balloons
2) By Scoring Balloons: Semi-Compliant Scoring Balloons, Non-Compliant Scoring Balloons
3) By Drug-Eluting Balloons: Paclitaxel-Eluting Balloons, Sirolimus-Eluting Balloons, Everolimus-Eluting Balloons
4) By Cutting Balloons: Balloon Catheters With Cutting Blades, Balloon Catheters With Radial Scoring Elements
What Long-Term Trends Will Shape The Future Growth Of The Angioplasty Balloons Industry?
Leading enterprises within the angioplasty balloon sector are concentrating their efforts on engineering novel solutions, exemplified by sophisticated balloon creation apparatuses designed to perfect the fabrication of high-pressure balloons vital for significant heart interventions. The specific technology referenced, the Advanced Medical Balloon Forming System, is instrumental in accurately producing compliant medical devices integrated into catheter assemblies. To illustrate this progress, in the month of June in 2024, Interface Catheter Solutions, a specialized catheter technology firm situated in the United States, introduced the BFM-5510 High Force Balloon Forming Machine. This cutting-edge, benchtop apparatus has been specifically developed for crafting both compliant and non-compliant polymer balloons essential for angioplasty, stent deployment, and other crucial cardiovascular treatments. Evolving from the design basis of the BFM-3310 model, the BFM-5510 HF utilizes molds crafted from beryllium copper to achieve exacting contours on extruded balloon tubing, thereby guaranteeing rigorous quality benchmarks and narrow tolerance adherence across a broad spectrum of dimensions and geometries. Furthermore, this machinery extends production capacities to effectively manage the needs associated with fabricating increasingly larger, denser, and more intricate medical balloons.
Who Are The Prominent Global Companies Shaping The Angioplasty Balloons Market?
Major companies operating in the angioplasty balloons market are Johnson & Johnson, Abbott Laboratories, Medtronic Plc, Becton Dickinson, Koninklijke Philips N.V, Boston Scientific Corporation, B. Braun SE, Terumo Corporation, Cook Medical, Biotronik SE, Merit Medical Systems Inc., Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, AngioDynamics, Cordis, SurModics, iVascular, Hexacath, Balton Sp, Cardionovum, QualiMed Innovative Medizinprodukte GmbH, Acrostak, Panmed US Inc., Translumina GmbH, Concept Medical Inc
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/angioplasty-balloons-global-market-report
How Do Regional Market Performances Compare Within The Angioplasty Balloons Industry?
North America was the largest region in the angioplasty balloons market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angioplasty balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Angioplasty Balloons Market Report:
https://www.thebusinessresearchcompany.com/customise?id=15509&type=smp
Browse Through More Reports Similar to the Global Angioplasty Balloons Market 2025, By The Business Research Company
Drug Coated Balloons Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/drug-coated-balloons-global-market-report
Drug Eluting Balloons Catheters Global Market Report 2025
Fiber Reinforced Plastic Vessels Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
